Wikidata entity: Q47495791
C₃₆H₄₂F₂N₆O₉ (P274)
Quantities
| P2067 | mass | 740.298157 |
| P3780 | active ingredient in | ... | Q47521762 (Levaquin) | Levaquin |
| P233 | canonical SMILES | String | CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P4770 | hydrated form of | ... | Q424193 (levofloxacin) | levofloxacin |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | O.C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4.C[C@H]5COC6=C(N7CCN(C)CC7)C(F)=CC8=C6N5C=C(C(O)=O)C8=O | ??? |
| P2175 | medical condition treated | ... | Q12192 (pneumonia) | pneumonia |
| P2175 | medical condition treated | ... | Q183344 (sinusitis) | sinusitis |
| P2175 | medical condition treated | ... | Q34879 (staphylococcal infection) | staphylococcal infection |
| P2175 | medical condition treated | ... | Q154882 (legionnaires' disease) | legionnaires' disease |
| P2175 | medical condition treated | ... | Q221668 (urinary tract infection) | urinary tract infection |
| P2175 | medical condition treated | ... | Q246084 (cystitis) | cystitis |
| P2175 | medical condition treated | ... | Q480700 (otitis) | otitis |
| P2175 | medical condition treated | ... | Q372752 (prostatitis) | prostatitis |
| P2175 | medical condition treated | ... | Q1066061 (diverticulitis) | diverticulitis |
| P2175 | medical condition treated | ... | Q1344812 (epididymitis) | epididymitis |
| P2175 | medical condition treated | ... | Q727028 (bacterial infectious disease) | bacterial infectious disease |
| P2175 | medical condition treated | ... | Q876887 (cellulitis) | cellulitis |
| P2175 | medical condition treated | ... | Q2085267 (pharyngitis) | pharyngitis |
| P2175 | medical condition treated | ... | Q3286546 (respiratory disease) | respiratory disease |
| P2175 | medical condition treated | ... | Q3776920 (bacterial pneumonia) | bacterial pneumonia |
| P2175 | medical condition treated | ... | Q3936113 (nasopharyngitis) | nasopharyngitis |
| P2175 | medical condition treated | ... | Q13046587 (pulmonary tuberculosis) | pulmonary tuberculosis |
| P2175 | medical condition treated | ... | Q17651228 (kidney infection) | kidney infection |
| P2175 | medical condition treated | ... | Q55779961 (chronic rhinosinusitis) | chronic rhinosinusitis |
| P2175 | medical condition treated | ... | Q56003062 (susceptibility to severe influenza) | susceptibility to severe influenza |
| P1748 | NCI Thesaurus ID | String | C1586 | ??? |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P279 | subclass of | ... | Q462174 (hydrate) | hydrate |
| P279 | subclass of | ... | Q426549 (quinolone) | quinolone |
| P231 | CAS Registry Number | 138199-71-0 |
| P661 | ChemSpider ID | 2298495 |
| P8494 | DSSTOX compound identifier | DTXCID2083024 |
| P3117 | DSSTox substance ID | DTXSID60160533 |
| P232 | EC number | 604-067-2 |
| P2566 | ECHA Substance Infocard ID | 100.113.636 |
| P234 | InChI | InChI=1S/2C18H20FN3O4.H2O/c2*1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h2*7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H2/t2*10-;/m00./s1 |
| P235 | InChIKey | SUIQUYDRLGGZOL-RCWTXCDDSA-N |
| P11199 | Probes And Drugs ID | PD087124 |
| P662 | PubChem CID | 3033924 |
| P3345 | RxNorm CUI | 82122 |
| P2877 | SureChEMBL ID | 1650602 |
| P11089 | UniChem compound ID | 24194255 |
| P652 | UNII | 6GNT3Y5LMF |
Why not click here or view trends?
log id: 2484412